against syphilis and gonorrhoea. Rumours of increases in the incidence and severity of reactions to penicillin are viewed with concern, for apprehension on the part of physicians charged with the responsibility of treating venereal disease patients could adversely affect the control programme. It was this concern which instigated a study of penicillin reactions which was conducted by the Public Health Service in 1954 with the cooperation of 24 treatment facilities representing fourteen states (Smith, Cutler, and Price, 1955) .
During the intervening 5-year period some deaths attributable to penicillin have been reported. In fact, a review of the death certificates in one State (Thorner and Bond, 1958) BRITISH JOURNAL OF VENEREAL DISEASES the totals in the groups do not necessarily agree with the grand total.
As in 1954, the highest reaction rate is found in patients treated for syphilis, the lowest in those treated for gonorrhoea. Unfortunately, the 1954 study failed to include in the questionnaire the amount of penicillin administered. It was reasoned that patients sensitive to the drug would react to small doses as readily as to large doses. This was fallacious reasoning, for in our current study the reaction rate increased from 4 5 per 1,000 treated with 1,200,000 to 2,400,000 units to 46-2 per 1,000 treated with 4,800,000 units or more. The difference in treatment schedules readily explains the apparent differences in the diagnostic groups. Changes in treatment schedules in the United States during the last 5 years could also account for the increased incidence of reactions. The standard penicillin dose for gonorrhoea in 1954 was 600,000 units. In the 1959 sample, 1,600 patients were given less than 1,200,000 units and 9,000 were treated with 1,200,000 to 2,400,000 units.
In 1954 it appeared that patients tolerated benzathine penicillin G better than procaine penicillin in oil (PAM). In the current series, the rates are practically the same, 11 * 7 for PAM and 12 * 5 for benzathine penicillin. Here again dosage schedules have changed in some clinics with doses of 4,800,000 to 9,600,000 units replacing the standard 2,400,000 benzathine dose employed in 1954. When the comparison is limited to those treated with 1,200,000 to 2,400,000 units, the reaction rates are 4*5 for benzathine penicillin, 5 1 for PAM, and 4 0 for these two types combined. 4,000 patients were given combined therapy in the above dosage; this was a schedule designed to produce both an initial high and a prolonged blood level for patients with gonorrhoea.
It is interesting that, when schedules are tabulated by duration, the reaction rates for the two studies differ significantly only in the single-session group. This is further evidence that more reactions were recorded because the patients were detained longer after receiving the injection.
It is the practice in most clinics to treat with other drugs patients who have previously shown sensitivity to penicillin. Therefore, few cases in either study fall into this classification. In both series approximately 10 per cent. of such patients experienced reactions-105 8 per 1,000 in 1959 and 99 2 per 1,000 in 1954, Of the 104 treated in 1959, 45 were given concomitant antihistamine therapy. The incidence of reactions in the group was less than half of that observed in the group without concomitant treatment-66 -7 compared with 135-6 per 1,000.
In 1954 it appeared that patients who had previously tolerated penicillin were less apt to react than patients who as far as was known had never been treated with penicillin. In the present series the reverse of this appears to be the case. The difference observed in 1954 between 3 9 and 9 1 was statistically significant at the 5 per cent. level. In the 1959 series the difference between 9 1 and 6 6 is not significant.
The 1959 study confirms the race-sex differences observed in 1954. Namely, the incidence of reactions is higher among females in both races and higher among white, in both sexes-or highest in white females and lowest in Negro males.
It appears in both series that the incidence of reactions increases with age. The age factor, however, is complicated by the amount of treatment administered. The young patients, in general, represent cases of gonorrhoea and low dosage schedules, while the older patients represent cases of syphilis and high dosage schedules. When limited to epidemiological treatment or treatment for gonorrhoea, the age differences are much less striking. The rates are 3 6, 5-6, and 6-4 per 1,000 for the three 10-year age groups between 10 and 40, the only three with sufficiently large numbers for comparison.
No deaths occurred during the period covered by the study in 1954, and to date, no deaths have been reported in the present series. Because of the large numbers of patients at risk in venereal disease treatment centres, emphasis has been placed on preparedness. Clinicians have been urged to have therapeutic materials and supplies ready for immediate use so that fatal reactions may be averted. The second factor is the increase since 1954 in the standard 600,000-unit dosage for gonorrhoea. The majority of the patients in the present series were treated with 1,200,000 or 1,800,000 units of penicillin, and some clinics were using schedules as high as 2,400,000 units for uncomplicated gonorrhoea.
Taking these two factors into consideration, the higher incidence of reactions reported in 1959 is in no way alarming and no essential changes in the present treatment practices seem to be indicated. Le deuxieme facteur est represente par l'augmentation depuis 1954 de la dose habituelle de 600.000 unites contre la blennorragie. La majorit6 des malades dans la serie presente furent traites par 1.200.000 ou 1.800.000 unites de penicilline, et certaines cliniques allaient meme jusqu'a 2.400.000 unites pour une simple blennorragie.
En prenant en consideration ces deux facteurs, la frequence augmentee des r6actions rapportee en 1959 n'est pas terrible et des modifications essentielles des methodes presentes de traitement ne sont pas indiquees.
